Equasens Société anonyme (EPA:EQS)

Market Cap	636.57M
Revenue (ttm)	215.16M
Net Income (ttm)	42.25M
Shares Out	15.03M
EPS (ttm)	2.78
PE Ratio	15.24
Forward PE	15.66
Dividend	1.25 (2.96%)
Ex-Dividend Date	Jul 2, 2024

Volume	14,322
Average Volume	11,725
Open	42.00
Previous Close	42.20
Day's Range	42.00 - 42.80
52-Week Range	30.55 - 67.40
Beta	0.85
RSI	74.45
Earnings Date	Sep 26, 2025

About Equasens Société anonyme

Equasens Société anonyme provides healthcare IT solutions in Europe. The company develops electronic equipment, digital and robotic health, and equipment lease financing solutions. It also offers id., a pharmacy management software suite; id. PATIENT for the exchange of healthcare data; id. VENTE, which facilitates and secures prescription sales; id. COMMANDE, which manages orders and inventory; dispensing robots; Ségur id. services; FARMACLICK, a communication protocol; DIFARM, a modular solution for wholesalers-distributors; and PHARE, a reta...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1996
• Employees: 1,271
• Stock Exchange: Euronext Paris
• Ticker Symbol: EQS

Financial Performance

In 2023, Equasens Société anonyme's revenue was 219.79 million, an increase of 2.67% compared to the previous year's 214.08 million. Earnings were 47.05 million, an increase of 1.45%.